NASDAQ:NAOV NanoVibronix (NAOV) News Today $2.24 -0.07 (-3.03%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$2.17▼$2.3550-Day Range$1.45▼$3.3152-Week Range$1.41▼$12.90Volume19,312 shsAverage Volume566,394 shsMarket Capitalization$3.72 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meetingfinance.yahoo.com - September 6 at 1:48 PMAMC, MMLP and ARAV among mid-day moversseekingalpha.com - August 31 at 6:23 AMNanoVibronix to raise $5M through private placementmsn.com - August 30 at 8:21 PMWhy Is NanoVibronix Stock Trading Higher Today?finance.yahoo.com - August 30 at 3:21 PMNanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rulesfinance.yahoo.com - August 30 at 3:21 PMWhy Is NanoVibronix (NAOV) Up 153% Today?investorplace.com - August 30 at 12:03 PMNanoVibronix Cites Positive Results from Independent Testing of UroShieldfinance.yahoo.com - August 30 at 10:05 AMNanoVibronix Responds to CMS’ Determination for PainShieldfinance.yahoo.com - August 29 at 6:52 PMNanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tarifffinance.yahoo.com - August 28 at 11:05 AMNanoVibronix Extends Distribution Deal With UPPI For PainShield, PainShield Plusmarkets.businessinsider.com - August 23 at 5:13 PMNanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plusfinance.yahoo.com - August 23 at 5:13 PMNanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guardfinance.yahoo.com - June 14 at 11:55 AMNanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guardfinance.yahoo.com - June 14 at 11:55 AMNanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)finance.yahoo.com - March 28 at 10:43 AMNanoVibronix Files Provisional U.S. Patent Application for UroShield Ultrafinance.yahoo.com - March 21 at 1:00 PMNanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injuryfinance.yahoo.com - March 14 at 9:58 AMNanoVibronix to Launch Rental Program for PainShield and UroShieldfinance.yahoo.com - February 22 at 9:46 AMNanoVibronix Announces Reverse Stock Splitfinance.yahoo.com - February 8 at 2:25 PMNanoVibronix Provides Update on Expanding Access to PainShieldfinance.yahoo.com - January 18 at 11:20 AMNAOV.O - NanoVibronix Inc | Stock Price & Latest News | Reutersreuters.com - December 31 at 6:22 PMNanoVibronix Announces Partnership with Peak Medical, Ltd.finance.yahoo.com - December 13 at 6:28 PMShareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation Acceptablefinance.yahoo.com - December 9 at 7:24 AMNanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - December 1 at 6:14 PMWhat Is Going on With NanoVibronix (NAOV) Stock Today?investorplace.com - November 29 at 10:43 AMNanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rulesfinance.yahoo.com - November 29 at 10:05 AMNanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plusfinance.yahoo.com - November 28 at 7:02 PMNanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021)finance.yahoo.com - November 17 at 9:28 AMNanoVibronix Announces Interim Results of Clinical Study for UroShieldfinance.yahoo.com - November 16 at 6:25 PMInterim Results Of NanoVibronix's Uroshield Show Beneficial Effects For Patientsfinance.yahoo.com - November 16 at 6:25 PMNanoVibronix, Inc. (NAOV) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - November 12 at 10:34 PMNANOVIBRONIX, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - October 19 at 11:47 AMNanoVibronix receives extension to satisfy Nasdaq bid price requirement - Seeking Alphaseekingalpha.com - October 19 at 11:47 AMNanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement - Business Wirebusinesswire.com - October 19 at 11:47 AMNanoVibronix Receives Extension to Satisfy Nasdaq Price Requirementfinance.yahoo.com - October 19 at 11:47 AMForm PRE 14A NanoVibronix, Inc. For: Oct 12 - StreetInsider.comstreetinsider.com - October 13 at 8:29 PMWhy LAVA Therapeutics Shares Are Trading Higher By 97%, Here Are 49 Stocks Moving In Monday's Mid-Day Session - Markets Insidermarkets.businessinsider.com - September 26 at 2:57 PMNanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract - Business Wirebusinesswire.com - September 23 at 6:45 PMThinking about buying stock in Avenue Therapeutics, Color Star Technology, T2 Biosystems, NanoVibronix, o - Benzingabenzinga.com - September 23 at 1:45 PMNANOVIBRONIX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - September 23 at 1:45 PMNanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract - Yahoo Financefinance.yahoo.com - September 23 at 8:45 AMNanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contractfinance.yahoo.com - September 23 at 8:45 AMNAOV.OQ - NanoVibronix Inc | Stock Price & Latest News | Reutersreuters.com - September 20 at 6:33 AMForm 8-K NanoVibronix, Inc. For: Sep 13 - StreetInsider.comstreetinsider.com - September 14 at 8:57 PMNANOVIBRONIX, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.commarketscreener.com - September 14 at 8:57 PMNanoVibronix Sets Date for Annual Shareholder Meetingfinance.yahoo.com - September 14 at 8:57 PMNanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock - Business Wirebusinesswire.com - September 14 at 10:53 AMNanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stockfinance.yahoo.com - September 14 at 10:52 AM2022-09-02 | NDAQ:NAOV | Press Release | NanoVibronix Inc. - Stockhousestockhouse.com - September 4 at 4:45 AMNanoVibronix (NAOV) – NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request - Benzingabenzinga.com - September 2 at 9:49 PMNanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearingfinance.yahoo.com - September 2 at 4:49 PM Get NanoVibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address NAOV Media Mentions By Week NAOV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAOV News Sentiment▼0.000.64▲Average Medical News Sentiment NAOV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAOV Articles This Week▼00▲NAOV Articles Average Week Get NanoVibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Heart Test Laboratories News Today Bone Biologics News Today Predictive Oncology News Today PolyPid News Today GRI Bio News Today Artelo Biosciences News Today Sonoma Pharmaceuticals News Today Aptevo Therapeutics News Today Soligenix News Today Revelation Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:NAOV) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.